Ensure your compounding operations remain safe, compliant, and reliable with a full suite of laboratory testing and environmental monitoring services designed specifically for compounding pharmacies. Innovotech is a proudly Canadian, GMP-accredited laboratory with over 20 years of experience, offering comprehensive testing solutions to support compliance with USP <797>, USP <800>, the National Association of Pharmacy Regulatory Authorities (NAPRA), and Health Canada.
A regular monitoring program is a key component of a strong quality system. Our services help you maintain effective control over personnel, facilities, and equipment while identifying microbial risks early, allowing you to take timely action and safeguard the integrity of your operations.
Why Innovotech
See how Innovotech stands apart from other contract testing laboratories serving Canadian compounding pharmacies.
Canadian, and Built for Pharmacies
Most contract laboratories are pharmaceutical manufacturing labs that pharmacies can also use. Innovotech’s compounding service line is built for pharmacies and mapped to NAPRA Model Standards alongside the USP compounding chapters, and every sample stays in Canada.
Sampling Support→Lab Analysis→Audit-Ready Report→CAPA Guidance
| Feature | Innovotech | Other Labs |
|---|---|---|
| Sterility & Endotoxin Testing to USP <71> and <85> Compendial sterility and bacterial endotoxin testing for compounded sterile preparations | YES | YES |
| NAPRA Model Standards Alignment Services mapped to NAPRA Model Standards clauses alongside the USP compounding chapters, rather than to US state pharmacy board frameworks | YES | UNCONFIRMED |
| Canadian Lab, No Cross-Border Shipping Samples stay in Canada. No customs paperwork, no border transit time, and no added risk to time-sensitive microbiological samples | YES | VARIES |
| Dedicated Compounding-Pharmacy Service Line A service line built for pharmacies, not a pharmaceutical manufacturing menu that pharmacies can also use | YES | VARIES |
| Operator Qualification: Glove Fingertip & Media Fill Personnel competency testing demonstrating ongoing aseptic technique, as expected under NAPRA and USP <797> | YES | VARIES |
| Hazardous Drug Surface Wipe Testing with Collection Kits Self-collection kits with sampling templates, prepaid return shipping and chain-of-custody documentation, not analysis alone | YES | VARIES |
| BUD & Stability Studies for Compounded Preparations Potency, sterility and stability data to support evidence-based Beyond-Use Date assignment | YES | VARIES |
| CAPA Support Included Our science team provides corrective and preventive action guidance to help pharmacies restore compliance quickly | YES | UNCONFIRMED |
Comparison reflects publicly available service information from Canadian and US contract testing laboratories reviewed in August 2026. Laboratory accreditation, service scope, and reporting features vary by provider and may change.
NAPRA (National Association of Pharmacy Regulatory Authorities) sets the standards for non-sterile and sterile compounding in Canada. These standards outline environmental monitoring, personnel qualification, and product testing requirements to ensure patient safety and product quality. NAPRA testing verifies that compounding pharmacies meet these regulatory expectations, including microbial control, cleanroom performance, and process validation.
Independent laboratory testing provides objective, defensible data that demonstrates compliance with regulatory standards such as NAPRA and USP requirements. Third-party testing strengthens quality assurance programs, supports inspection readiness, and ensures compounded preparations meet required safety and quality standards before reaching patients.
Innovotech supports sterile compounding pharmacies through validated sterility testing, endotoxin testing, environmental monitoring programs, and microbial identification services. Our laboratory operates under a robust quality management system to ensure reliable, audit-ready data. We also assist with interpreting results, trending environmental data, and supporting corrective actions when required.
Hazardous drug (HD) testing evaluates whether trace amounts of cytotoxic or other hazardous compounds are present on surfaces within a compounding environment. Pharmacies that prepare hazardous drugs must demonstrate that containment controls, cleaning procedures, and engineering controls are effective in preventing cross-contamination and protecting personnel. Surface sampling and analytical testing provide objective evidence that decontamination and cleaning protocols are working as intended and support compliance with NAPRA and USP <800> guidelines.
If testing results exceed action limits or specifications, Innovotech provides prompt notification and detailed reporting. Our team supports pharmacies with microbial identification, data interpretation, and technical insight to assist with root cause investigations and corrective and preventive actions (CAPA). Our goal is to help pharmacies quickly address issues, restore compliance, and maintain patient safety.
